Previous close | 142.68 |
Open | 143.21 |
Bid | 141.59 x 1100 |
Ask | 143.54 x 1000 |
Day's range | 141.96 - 143.38 |
52-week range | 87.59 - 144.03 |
Volume | |
Avg. volume | 1,117,312 |
Market cap | 34.748B |
Beta (5Y monthly) | 1.08 |
PE ratio (TTM) | 49.76 |
EPS (TTM) | 2.88 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | 1.44 (1.00%) |
Ex-dividend date | 20 Feb 2024 |
1y target est | 145.71 |
Does Xylem (XYL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Xylem Inc. (XYL) continued its streak of surpassing revenue expectations.
Xylem (XYL) benefits from strength in the M&CS segment and the acquisition of Evoqua. Its measures to reward its shareholders are encouraging.